Finland
Viven is at the forefront of transforming women's health by leveraging cutting-edge technology with expert medical insights. Established in 2023, this Finnish startup caters to women over 35, particularly those navigating their perimenopausal years. By blending the expertise of Europe's leading women's health specialists with technological innovations, Viven delivers a comprehensive health assessment like no other.
The company's approach combines blood biomarker analysis with detailed data on symptoms, lifestyle, and personal health goals. This integration allows for a personalized, science-based action plan tailored for each client by a specialist in women's health. This unique value proposition positions Viven as a potential game-changer in women's healthcare, emphasizing both affordability and comprehensive care.
For investors, Viven presents an exciting opportunity to support a burgeoning segment of the healthcare industry with a strong foundation in evidence-based science and a target demographic with increasing health awareness.
